| Literature DB >> 18261226 |
Markus Thiersch1, Wolfgang Raffelsberger, Rico Frigg, Marijana Samardzija, Andreas Wenzel, Olivier Poch, Christian Grimm.
Abstract
BACKGROUND: Retinal degeneration is a main cause of blindness in humans. Neuroprotective therapies may be used to rescue retinal cells and preserve vision. Hypoxic preconditioning stabilizes the transcription factor HIF-1alpha in the retina and strongly protects photoreceptors in an animal model of light-induced retinal degeneration. To address the molecular mechanisms of the protection, we analyzed the transcriptome of the hypoxic retina using microarrays and real-time PCR.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18261226 PMCID: PMC2270833 DOI: 10.1186/1471-2164-9-73
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Transient protection of retinal morphology by hypoxic preconditioning. A) BALB/c mice were preconditioned by hypoxia for 6 h. After 4 h, 8 h, 12 h or 16 h of reoxygenation in darkness, mice were exposed to 5'000 lux of white light for 1 h. Control animals were not preconditioned and were (normoxic) or were not (dark control) exposed to light. Retinal morphology was analyzed 36 h after light exposure. Normoxic animals exposed to light showed a severe disruption of ROS and RIS with the appearance of many pycnotic photoreceptor nuclei. Mice exposed to light 4 hours after hypoxic preconditioning were almost completely protected and only some ROS vesiculation was observed. The protective effect of hypoxia was progressively weakened with increasing reoxygenation time before illumination as indicated by an increased disruption of ROS and RIS and the increased appearance of pycnotic photoreceptor nuclei. 16 h after preconditioning the protection was completely lost. Hypoxic preconditioning per se did not affect retinal morphology or function even after prolonged survival (data not shown, [9]). Arrowheads: examples of pycnotic nuclei; ROS: rod outer segments; RIS: rod inner segments; ONL: outer nuclear layer, scale bar: 25 μm. B) Expression of transcription factors HIF-1α and phospho-STAT3 in the retina was analyzed in normoxic mice or immediately after hypoxic preconditioning by Western blotting. β-actin and STAT3 levels verified equal sample loading. Both transcription factors were induced immediately after hypoxia with some variability between individuals. Shown are results from two normoxic controls and from two mice preconditioned with hypoxia.
Figure 2Number of genes differentially expressed immediately (0 h), 2 h, 4 h and 16 h after hypoxic preconditioning. Gray bars: total number of significantly regulated genes. White bars: number of genes regulated at least 2-fold. The number of differentially regulated genes decreased rapidly during reoxygenation, indicating a fast return to the gene expression pattern of normoxic retinas.
Top 50 differentially regulated genes immediately after hypoxic preconditioning
| UPREGULATED | ||||
| 1440257_at | Obox6 | oocyte specific homeobox 6 | 118.4 | 2.48E-07 |
| 1433837_at | 8430408G22Rik | RIKEN cDNA 8430408G22 gene | 35.6 | 6.94E-05 |
| 1424638_at | Cdkn1a | cyclin-dependent kinase inhibitor 1A (p21) | 30.5 | 3.00E-05 |
| 1454409_at | 4833408G04Rik | RIKEN cDNA 4833408G04 gene | 24.0 | 2.07E-06 |
| 1418190_at | Pon1 | paraoxonase 1 | 22.5 | 1.98E-05 |
| 1422832_at | Rgr | retinal G protein coupled receptor | 22.1 | 6.20E-05 |
| 1454608_x_at | Ttr | transthyretin | 20.1 | 2.67E-04 |
| 1455913_x_at | Ttr | transthyretin | 20.0 | 3.11E-04 |
| 1458610_at | - | --- | 17.4 | 1.95E-04 |
| 1416434_at | Bcl2l10 | Bcl2-like 10 | 17.0 | 2.70E-05 |
| 1444487_at | Lrat | lecithin-retinol acyltransferase | 16.2 | 6.54E-06 |
| 1441228_at | Apold1 | apolipoprotein L domain containing 1 | 11.7 | 7.21E-05 |
| 1438815_at | Hist2h2aa2 | histone 2, H2aa2 | 10.7 | 1.01E-04 |
| 1416077_at | Adm | adrenomedullin | 10.6 | 2.48E-04 |
| 1430197_a_at | Pitpnm2 | phosphatidylinositol transfer protein, membrane-associated 2 | 10.3 | 5.36E-05 |
| 1428942_at | Mt2 | metallothionein 2 | 9.7 | 5.12E-06 |
| 1418808_at | Rdh5 | retinol dehydrogenase 5 | 9.7 | 9.82E-05 |
| 1427221_at | MGI:2143217 | X transporter protein 3 similar 1 gene | 9.3 | 1.29E-04 |
| 1430817_at | Samd7 | sterile alpha motif domain containing 7 | 8.6 | 2.66E-04 |
| 1447494_at | D7Bwg0826e | DNA segment, Chr 7, Brigham & Women's Genetics 0826 expressed | 7.2 | 5.77E-06 |
| 1428352_at | Arrdc2 | arrestin domain containing 2 | 7.1 | 6.05E-05 |
| 1446587_at | - | Transcribed locus | 6.9 | 2.32E-04 |
| 1424838_at | A330049M08Ri | RIKEN cDNA A330049M08 gene | 6.8 | 1.21E-04 |
| 1426117_a_at | Slc19a2 | solute carrier family 19 (thiamine transporter), member 2 | 6.8 | 1.80E-04 |
| 1430357_at | H3f3b | H3 histone, family 3B | 6.3 | 5.84E-05 |
| 1422557_s_at | Mt1 | metallothionein 1 | 6.3 | 5.42E-06 |
| 1454991_at | Slc7a1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 6.1 | 1.39E-04 |
| 1429348_at | Sema3c | semaphorin 3C | 5.9 | 3.55E-04 |
| 1442366_at | 6820408C15Ri | RIKEN cDNA 6820408C15 gene (6820408C15Rik), mRNA | 5.6 | 6.15E-05 |
| 1441673_at | C80120 | expressed sequence C80120 | 5.3 | 1.39E-04 |
| DOWNREGULATED | ||||
| 1429169_at | Rbm3 | RNA binding motif protein 3 | 19.41 | 2.54E-04 |
| 1435692_at | LOC622320 | similar to retinoic acid, EGF, and NGF upregulated | 7.02 | 3.79E-05 |
| 1447363_s_at | Bub1b | budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) | 6.36 | 8.09E-06 |
| 1416961_at | Bub1b | budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) | 5.41 | 1.20E-06 |
| 1444172_at | - | Transcribed locus | 4.72 | 2.64E-04 |
| 1435158_at | Rbm12b | RNA binding motif protein 12B | 4.40 | 6.09E-05 |
| 1425083_at | Otor | otoraplin | 4.03 | 2.21E-04 |
| 1445709_at | Mdm1 | transformed mouse 3T3 cell double minute 1 | 3.97 | 1.64E-04 |
| 1450953_at | Wdr39A | WD repeat domain 39 | 3.70 | 1.93E-04 |
| 1456723_at | Prr14 | Proline rich 14 | 3.49 | 2.35E-05 |
| 1456834_at | Ibrdc2 | IBR domain containing 2 (Ibrdc2), mRNA | 3.45 | 1.76E-04 |
| 1442051_at | His2h3cl | histone 2, H3c1 | 3.39 | 2.63E-04 |
| 1437647_at | Dido1 | death inducer-obliterator 1 | 3.38 | 6.54E-05 |
| 1421379_at | Zfp354b | zinc finger protein 354B | 3.28 | 3.41E-04 |
| 1424852_at | Mef2c | myocyte enhancer factor 2C | 3.22 | 1.40E-04 |
| 1429655_at | Nudcd1 | Nudcd1 NudC domain containing 1 3.19 3.84E-04 | 3.19 | 3.84E-04 |
| 1442249_at | - | Transcribed locus | 3.11 | 1.03E-04 |
| 1416920_at | Rbm4 | RNA binding motif protein 4 | 3.11 | 1.44E-04 |
| 1460107_at | 1700129I04Rik | RIKEN cDNA 1700129I04 gene | 3.11 | 1.74E-04 |
| 1453010_at | Iws1 | IWS1 homolog (S. cerevisiae) | 2.98 | 2.80E-04 |
FC: fold change; pVal: p-value
Figure 3Expression of candidate genes analyzed by real-time PCR. Expression profile of p21 (Cdkn1a), Pon1 (paraoxonase 1) Ttr (transthyretin) and Adm (adrenomedullin) immediately after hypoxic exposure (0 h), or after a period of 2 h, 4 h or 16 h of reoxygenation as determined by real-time PCR. Fold-changes are expressed relative to normoxic controls of respective time points, which were set to one. n = 5 for each treatment and time point. White bars: samples of normoxic retinas, grey bars: samples of hypoxic preconditioned retinas; *** p ≥ 0.001, ** p ≥ 0.01, * p ≥ 0.05).
Differentially regulated genes with possible impact on cell survival and neuroprotection; detected and functionally clustered by DAVID.
| Up-regulated | |||
| apoptosis (p ≥ 0.032) | |||
| 1424638_at | Cdkn1a | cyclin-dependent kinase inhibitor 1a (p21) | 30.5 |
| 1416434_at | Bcl2l10 | Bcl2-like 10 | 17.0 |
| 1442025_a_at | Zbtb16 | zinc finger and btb domain containing 16 | 3.6 |
| 1454109_a_at | Ptdsr | phosphatidylserine receptor | 2.4 |
| 1420909_at, 1451959_a_at | Vegfa | vascular endothelial growth factor a | 2.3 |
| 1453851_a_at | Gadd45g | growth arrest and dna-damage-inducible 45 gamma | 2.3 |
| 1452050_at | Camk1d | calcium/calmodulin-dependent protein kinase id | 2.1 |
| 1454903_at | Ngfr | nerve growth factor receptor (TNFR superfamily, member 16) | 2.0 |
| cell cycle (p ≥ 0.013) | |||
| 1424638_at | Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 30.5 |
| 1416309_at | Nusap1 | nucleolar and spindle associated protein 1 | 4.4 |
| 1454018_at | Tlk2 | tousled-like kinase 2 (Arabidopsis) | 4.3 |
| 1449007_at | Btg3 | B-cell translocation gene 3 | 4.2 |
| 1424143_a_at, 1424144_at | Cdt1 | retroviral integration site 2 | 3.4 |
| 1419024_at, 1455002_at | Ptp4a1 | protein tyrosine phosphatase 4a1 | 2.7 |
| 1453851_a_at | Gadd45g | growth arrest and DNA-damage-inducible 45 gamma | 2.3 |
| 1420909_at, 1451959_a_at | Vegfa | vascular endothelial growth factor A | 2.3 |
| 1459978_x_at | - | gene model 877 (NCBI) | 2.0 |
| 1435870_at | Sycp3 | synaptonemal complex protein 3 | 2.0 |
| negative regulation of transcription (p ≥ 0.031) | |||
| 1442025_a_at | Zbtb16 | zinc finger and btb domain containing 16 | 3.6 |
| 1425809_at | Fabp4 | Fatty acid binding protein 4, adipocyte (Fabp4), mRNA | 3.5 |
| 1425895_a_at | Id1 | inhibitor of DNA binding 1 | 3.1 |
| 1442397_at | Nfx1 | nuclear transcription factor, X-box binding 1 | 2.7 |
| 1425732_a_at | Mxi1 | Max interacting protein 1 | 2.1 |
| Down-regulated | |||
| regulation of transcription (p ≥ 0.09) | |||
| 1440343_at | Rps6ka5 | ribosomal protein S6 kinase, polypeptide 5 | 0.42 |
| 1450034_at | Stat1 | signal transducer and activator of transcription 1 | 0.47 |
| 1416826_a_at | Trfp | Trf (TATA binding protein-related factor)-proximal protein homolog (Drosophila) | 0.41 |
| 1450953_at | Wdr39 | WD repeat domain 39 | 0.27 |
| 1421379_at | Zfp354b | zinc finger protein 354B | 0.31 |
| 1424852_at | Mef2c | myocyte enhancer factor 2C | 0.31 |
| 1437647_at | Dido1 | death inducer-obliterator 1 | 0.30 |
| 1443952_at | Thra | thyroid hormone receptor alpha | 0.48 |
| 1428760_at | Snapc3 | small nuclear RNA activating complex, polypeptide 3 | 0.40 |
| 1456723_at | Prr14 | Proline rich 14 | 0.29 |
Analysis of the gene expression pattern was immediately after hypoxia; FC: fold change
Figure 4The most prominently affected gene network discovered by Ingenuity Pathway Analysis. Network was classified as: Cellular growth & proliferation, DNA replication, recombination & repair. Pathway contains pro survival genes like Egf, Vegf and p21, which occupy central positions in this network. Red: induction; green: repression; white: unaffected; colour intensity correlates with fold change.
Real-Time PCR results of 16 genes belonging to the p21 pathway compared to the fold change (FC) detected by Affymetrix microarrays.
| Cdkn1a (p21) | 30.5 | 20.3* |
| Sema3c | 5.9 | 3.9* |
| Egf | 4.7 | 2.8* |
| HMGB2 | 4.1 | 3.0* |
| Fabp4 | 3.5 | 5.3* |
| CEBPd | 3.5 | 3.5* |
| Timp3 | 3.3 | 3.7* |
| ID1 | 3.1 | 1.8* |
| Rad23b | 2.6 | 1.2 |
| Vegf | 2.3 | 2.0* |
| Stom | 2.0 | 1.3 |
| Hes6 | 1.9 | 1.6* |
| SOS1 | 1.9 | 0.9 |
| Stat1 | 0.5 | 1.1 |
| Thra | 0.5 | 0.8 |
| IBRDC2 | 0.3 | 0.9 |
Analysis of gene expression was immediately after hypoxia
FC: fold change. * p < 0.05
Figure 5Role of p21 in hypoxic preconditioning. Hypoxic preconditioned (hypoxia) or normoxic (normoxia) p21-/- mice were exposed to 13'000 lux of white light for 2 hours and retinal morphology was analyzed 10 days thereafter. Dark-adapted knockout mice served as controls (dark control). Hypoxic preconditioning almost completely protected the retina of p21-/- mice leading to a retinal morphology indistinguishable from controls. Exposure of normoxic mice led to a complete degeneration of photoreceptors in the central retina. Shown are representative samples of control and light exposed mice. n = 2 (controls); n = 4 (light exposed mice). Abbreviations as in Fig. 1. Scale bar: 25 μm.